Difficulty: Medium
Average Score: 89%
Practice
Which of the following antidiabetic drugs is most suitable for treatment of diabetes during pregnancy?
Correct answer
C
Rationale
In the context of treating diabetes during pregnancy, the most suitable antidiabetic drug is insulin (Option C). Insulin is considered the safest and most effective option for managing blood sugar levels in pregnant women with diabetes.
Insulin does not cross the placenta, ensuring that it does not affect the fetus directly. It helps to maintain stable blood glucose levels for both the mother and the developing baby. Additionally, insulin therapy can be tailored to the specific needs of the pregnant woman, adjusting doses as necessary to accommodate changes in hormone levels and insulin resistance during pregnancy.
On the other hand, the other options are not recommended for use in pregnancy due to various reasons. Rosiglitazone (Option A) has been associated with an increased risk of cardiovascular events and is contraindicated in pregnancy. Acarbose (Option B) is not commonly used during pregnancy due to limited safety data. Glipizide (Option D) belongs to a class of medications (sulfonylureas) that may not be as safe or effective in pregnancy compared to insulin.
In an educational context, it is crucial for healthcare providers to understand the implications of choosing appropriate medications for pregnant women with diabetes. Insulin remains the first-line therapy for managing diabetes during pregnancy due to its safety profile and effectiveness in controlling blood sugar levels without posing risks to the developing fetus. Healthcare professionals should be familiar with these guidelines to ensure optimal outcomes for both the mother and the baby.
Insulin does not cross the placenta, ensuring that it does not affect the fetus directly. It helps to maintain stable blood glucose levels for both the mother and the developing baby. Additionally, insulin therapy can be tailored to the specific needs of the pregnant woman, adjusting doses as necessary to accommodate changes in hormone levels and insulin resistance during pregnancy.
On the other hand, the other options are not recommended for use in pregnancy due to various reasons. Rosiglitazone (Option A) has been associated with an increased risk of cardiovascular events and is contraindicated in pregnancy. Acarbose (Option B) is not commonly used during pregnancy due to limited safety data. Glipizide (Option D) belongs to a class of medications (sulfonylureas) that may not be as safe or effective in pregnancy compared to insulin.
In an educational context, it is crucial for healthcare providers to understand the implications of choosing appropriate medications for pregnant women with diabetes. Insulin remains the first-line therapy for managing diabetes during pregnancy due to its safety profile and effectiveness in controlling blood sugar levels without posing risks to the developing fetus. Healthcare professionals should be familiar with these guidelines to ensure optimal outcomes for both the mother and the baby.